Ciaran J. McMullan
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0001-7269-6391Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial”.
Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more
Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more
Andrew W. McHill, Joseph T. Hull, Wei Wang, John P. Forman, Elizabeth B. Klerman +1 more
Muhammad Usman, Kevin J. Anstrom, Robert O. Blaustein, Marc P. Bonaca, Justin A. Ezekowitz +14 more
Haifeng Guo, Dena Rosen Ramey, Ciaran J. McMullan, G. Brandon Atkins, James B. Wetmore +1 more
Sarah Rathwell, Devan V. Mehrotra, Stefano Corda, Ciaran J. McMullan, Carolyn S.P. Lam +13 more